To study the mechanism(s) controlling expression of the tumor-associated aldehyde dehydrogenase (tumor ALDH), which appears during rat hepatocarcinogenesis, cDNAs encoding this isozyme were cloned and identified with an antibody probe. Poly(A)-containing RNA from HTC rat hepatoma cells, which have been shown to possess high levels of tumor ALDH, was used as template to synthesize double-stranded cDNA. The cDNA was methylated to protect internal sites. Two different synthetic DNA linkers were added sequentially to the cDNA to insure correct orientation for expression from the lac promoter of pUC8. A library of 100,000 independent members carrying inserts >1 kilobase was obtained. From this library, two apparently identical tumor ALDH clones, differing only in size, were identified with an indirect immunological probe. The larger of the cDNA clones identified, pTALDH, was chosen for further study. Interestingly, since tumor ALDH is a dimeric enzyme, pTALDH directs synthesis of a functional tumor ALDH in the bacterial cell. The cDNA sequence has been confirmed by comparison to the amino acid sequence of tumor ALDH purified from HTC cells.
Previous work has shown that a tumor-associated aldehyde dehydrogenase (tumor ALDH) can be induced by a number of different chemical carcinogens during rat hepatocarcinogenesis (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . This phenotype is characterized by an increase in total ALDH activity due to the appearance of a cytosolic isozyme undetectable in normal rat liver. This isozyme preferentially oxidizes aromatic aldehyde substrates using NADP+ as coenzyme and differs from normal liver ALDH isozymes in a number of physical and functional properties (1, 4, 12, 13) .
The tumor ALDH isozyme has been purified from a variety of sources and its properties have been described (1, 13, 14) . The tumor ALDH isozyme has a Mr of 110,000 and is composed of two apparently identical subunits. While the tumor ALDH isozyme shares identical subunit size (Mr. 54 ,000) with the normal liver ALDH isozymes, it is a distinctly different enzymatic species based on electrophoretic mobility, isoelectric point, sensitivity to inhibitors, substrate and coenzyme preference, and immunologic crossactivity (1, 4, (12) (13) (14) (15) .
In normal rat liver, ALDH activity is localized primarily to the mitochondrial and microsomal fractions (4, 12, 15, 16) . At least three distinct ALDH isozymes can be differentiated on the basis of substrate and coenzyme preference, substrate and coenzyme Ki,, and sensitivity to inhibitors (4, 12, 15, 16) . Generally, the normal liver isozymes are tetramers that preferentially oxidize aliphatic aldehydes using NAD+ as coenzyme.
Another ALDH isozyme can be induced in normal liver by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (13, (17) (18) (19) . Both the tumor ALDH isozyme and the TCDD-inducible isozyme have Mrs of 110,000 and preferentially oxidize aromatic aldehyde substrates using NADP+ as coenzyme. By all criteria, these isozymes appear to be identical (13) (14) (15) (16) (17) (18) (19) .
We have previously shown (2) that the appearance of the tumor ALDH isozyme during hepatocarcinogenesis is not due to derepression of a fetal ALDH gene. This gene product is also not found in regenerating liver after partial hepatectomy (10) . However, we have recently shown that an enzymatic species very similar to the tumor ALDH isozyme is found in normal rat urinary bladder (20) .
To study the regulation of tumor ALDH gene expression, we elected to clone a tumor ALDH cDNA. We chose the well-established rat hepatoma cell line HTC as a source of mRNA because previous studies have shown that these cells possess constitutively high levels of tumor ALDH activity (14, 21) , accounting for "1% of the total soluble protein in these cells (unpublished data). Compared to other sources, such as primary tumors, the extremely high tumor ALDH activity should reflect relatively high levels of tumor ALDH mRNA in HTC cells.
To maximize the chances of obtaining full-length cDNA clones, the cDNA prepared from HTC mRNA was further manipulated. The cDNA was methylated with EcoRI methylase and Pst I methylase to protect any internal restriction endonuclease sites of these enzymes. In addition, EcoRI and Pst I linkers were added sequentially to the cDNA to insure correct orientation for expression from the lac promoter of pUC8.
The identification and complete nucleotide sequence of a cDNA encoding the tumor ALDH monomer are described here. § Interestingly, the immunologically detected cDNA clone directs synthesis of very high levels of functional tumor ALDH.
EXPERIMENTAL PROCEDURES
Antigen and Antibody Preparation. Tumor ALDH was purified from HTC cells grown in spinner culture by ammonium sulfate precipitation and passage over a 5'-AMP Sepharose column as described (13, 14) .
High titer anti-tumor ALDH antisera were raised in rabbits with Freund's adjuvant used to enhance immunogenicAbbreviations: ALDH, aldehyde dehydrogenase; tumor ALDH, tumor-associated ALDH; TCDD, 2,3,7,8-tetrachlorodibenzo-pdioxin.
tTo whom reprint requests should be addressed. §This sequence is being deposited in the EMBL/GenBank data base (Bolt, Beranek, and Newman Laboratories, Cambridge, MA, and Eur. Mol. Biol. Lab., Heidelberg) (accession no. J03637).
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ity. The specificity of this antisera to tumor ALDH and the lack of cross-reactivity between other ALDH isozymes was tested by Ouchterlony double diffusion (22) . The IgG fraction of the anti-tumor ALDH antisera was purified by ammonium sulfate precipitation followed by passage over a combined DEAE-/CM-cellulose column (23, 24) . The purified IgG fraction was preadsorbed to an Escherichia coli extract before screening the cDNA library (25) .
Preparation of Poly(A)+ RNA and Synthesis of cDNA. Polysomal RNA was isolated from HTC cells grown in spinner culture by the sucrose block-gradient method (26, 27) . Poly(A)-containing RNA was purified from total polysomal RNA by two cycles of adsorption and elution from oligo(dT)-cellulose (28, 29) . Total RNA, poly(A)-containing RNA, and non-poly(A)-containing RNA, were translated in a rabbit reticulocyte translation system (Bethesda Research Laboratories). The presence of tumor ALDH in the translation products was confirmed by immunoprecipitation (30, 31) using anti-tumor ALDH antibodies and analyzed by NaDodSO4/polyacrylamide gel electrophoresis (32) . Double-stranded cDNA was synthesized by using avian myeloblastosis virus reverse transcriptase (Life Sciences, St. Petersburg, FL) as described by Maniatis et al. (29) . The cDNA was methylated to protect any internal sites using EcoRI and Pst I methylases (New England Biolabs) (33) . EcoRI and Pst I linkers were ligated to the cDNA sequentially to insure correct orientations for expression from the lac promoter of pUC8 (29, 33, 34) . The cDNA was cleaved with both EcoRI and Pst I restriction endonucleases (New England Biolabs). DNA >1 kilobase (kb) was prepared by agarose gel electrophoresis and then ligated into EcoRI/Pst I-cut pUC8. Recombinant plasmids were used to transform E. coli strain HB101 (Bethesda Research Laboratories).
Antibody screening of the cDNA library was performed by using purified anti-tumor ALDH IgG and an anti-rabbit IgG/horseradish peroxidase-conjugated second antibody (Sigma). Indirect immunologic screening was performed as described (35) using 4-chloro-1-naphthol as substrate for the horseradish peroxidase reaction.
Characterization of the cDNA. The location of restriction endonuclease cleavage sites within the cDNA insert was determined by digesting the DNA with restriction enzymes under the conditions recommended by the manufacturer. The sizes of the DNA fragments were determined by agarose gel electrophoresis (29) .
RNA blot analysis was performed using poly(A)-containing RNA from HTC cells and normal rat liver (29) . RNA preparations were electrophoresed with 1.2% agarose gels containing formaldehyde (29) . RNA was then transferred to a nitrocellulose filter and hybridized to a nick-translated 32P-labeled cDNA probe (29) . The washed filters were autoradiographed with an intensifying screen at -80°C using Kodak X-Omat AR x-ray film.
Preparation of Cell Extracts. E. coli strain HB101 containing pTALDH was grown overnight on a shaking incubator in 1% (wt/vol) Bacto-tryptone/1% (wt/vol) yeast extract/0.5% (wt/vol) sodium chloride/50 ,tg of ampicillin per ml.
E. coli cells were harvested by centrifugation at 15,000 x g for 10 min and washed in 60 mM sodium phosphate buffer (pH 8.5) containing 1 mM EDTA and 1 mM 2-mercaptoethanol. This and all further manipulations were carried out at 0°C-4°C. The (39) .
Amino Acid Sequence Analysis. Amino acid sequence analysis of purified tumor ALDH was performed as described (40) (41) (42) (43) (43) .
RESULTS
The presence of the tumor ALDH in both primary tumors and in HTC cells should also be reflected in the mRNA populations expressed in these cells. Tumor ALDH translation products from in vitro translation were readily detectable in the poly(A)-containing RNA of HTC cells (Fig. 1) A restriction map of the pTALDH clone demonstrates that three Pst I sites were protected by the methylation step in the cDNA cloning (Fig. 2) . This cDNA is -1.8 kb long and appears to contain the entire tumor ALDH coding sequence.
RNA blot analysis of poly(A)-containing RNA from HTC cells with pTALDH used as a probe reveals a species of seen in the extract of normal rat liver or in untransformed E. coli strain HB101.
It is also noteworthy, since tumor ALDH functions as a multimer (dimer) with relatively large (M, 50,000) subunits, that the pTALDH cDNA encodes a functional ALDH that possesses many properties of tumor ALDH (Table 1 ) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Like authentic tumor ALDH, the pTALDH-encoded polypeptide prefers aromatic aldehydes as substrate and NADP+ as coenzyme. Nondenaturing polyacrylamide gel electrophoresis followed by ALDH activity staining shows that the pTALDH-encoded ALDH comigrates with tumor ALDH activity from both HTC cells and a hepatocellular carcinoma (data not shown). The strategy for sequencing the pTALDH cDNA involves the insertion of restriction fragments or exonuclease III deletion fragments from pTALDH into pTZ plasmids (Fig.  2) . The length of the pTALDH cDNA is 1780 base pairs, including the two linkers added during the cloning procedure (Fig. 3) . The pTALDH cDNA contains 173 nucleotides of 5' noncoding sequence and 247 nucleotides of 3' noncoding sequence. The coding region of this cDNA begins with the initiation codon (ATG) at nucleotide 174 of the cDNA and extends through nucleotide 1532 (1359 bases). An opal (TGA) stop codon is present at nucleotide 1533 of the cDNA. The coding sequence encodes a polypeptide of 453 amino acids of Mr 50,209. The ATG codons of the lacZ gene and at nucleotide 104 of the cDNA were ruled out as start codons since stop codons would be encountered at nucleotides 23 and 188 of the cDNA, respectively. The pTALDH cDNA also possesses a poly(A) tail of 50 nucleotides.
The polypeptide encoded by the pTALDH cDNA has been confirmed by primary structural analysis of tumor ALDH isolated from HTC cells (Fig. 3) . Both authentic ALDH isolated from HTC cells and the enzyme expressed by the pTALDH-containing E. coli HB101 were submitted to Edman degradation. The enzyme from HTC cells was refractive to direct Edman degradation, indicating a blocked N terminus. In contrast, the results from 10 cycles of Edman degradation using the enzyme expressed in E. coli are consistent with the N terminus given (Fig. 3) . Thus, the bacterially produced ALDH polypeptide does not possess the leader peptide sequence of the lacZ gene product (34) .
DISCUSSION
A cDNA encoding the tumor ALDH of rat liver has been cloned, isolated, and confirmed by a variety of techniques. Interestingly, this clone, pTALDH, produces a functional dimeric tumor ALDH molecule as demonstrated by traditional assay procedures and nondenaturing gel electrophoresis. In addition, the protein produced by E. coli containing pTALDH begins with the same sequence (although with a free N terminus), has the same subunit molecular weight, and displays the same preference for aromatic aldehydes and NADP+ as substrate and coenzyme as authentic tumor ALDH (1-15) . Moreover, the polypeptide encoded by pTALDH is immunologically cross-reactive with anti-tumor ALDH antibodies by immunoblot analysis.
The cloning strategy used here offers a high probability of obtaining a full-length cDNA clone. Methylation protects against internal cleavage by restriction enzymes while preparing the linker ends of the cDNA for ligation. The sequential addition of the two linkers insures that all clones will be correctly oriented for expression from the lac promoter of a pUC-type plasmid. If a full-length clone is desired, gel purification of cDNAs at least as large as that necessary to Another cDNA clone encoding the TCDD-inducible ALDH isozyme has been separately isolated and confirmed (T. Dunn, personal communication). Identical restriction enzyme sites are found within the TCDD-inducible ALDH cDNA and the tumor ALDH cDNA. RNA blot analysis of RNA from livers of rats exposed to TCDD also shows a mRNA species migrating at :1L8 kb. No hybridization using the TCDD-inducible ALDH cDNA is seen with mRNA from normal rat liver. Therefore, it appears that these two inducible ALDH isozymes are encoded by the same gene.
Sequence analysis of the pTALDH cDNA identifies an open reading frame encoding a polypeptide with a molecular weight comparable to the tumor ALDH present in vivo (13, 14) . The two ATG codons upstream from the translation start codon (i.e., the ATG codons of the lacZ gene and the ATG at nucleotide 104 of the cDNA; see Fig. 3 ) were ruled out as initiator codons since they encounter stop codons at nucleotides 23 and 188, respectively. The amino acid composition of a blocked tryptic peptide is also consistent with an N-terminal tryptic fragment that would be generated if translation started at nucleotide 174 (unpublished data).
Interestingly, E. coli transformed with pTALDH expresses an active protein with a free N terminus that does not include any lacZ residues. Rather, the sequence obtained corresponds exactly to that expected for HTC ALDH, but without the N-terminal blocking group. Whether this is a result of a difference in sequence recognition specificity of the host acetylation system is not known. 
